SG Americas Securities LLC increased its holdings in The Clorox Company (NYSE:CLX – Free Report) by 489.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 115,252 shares of the company’s stock after acquiring an additional 95,691 shares during the period. SG Americas Securities LLC owned about 0.09% of Clorox worth $18,718,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Insight Folios Inc lifted its position in shares of Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after purchasing an additional 63 shares in the last quarter. HCR Wealth Advisors lifted its position in Clorox by 1.0% in the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock worth $1,116,000 after buying an additional 68 shares in the last quarter. SPC Financial Inc. boosted its stake in shares of Clorox by 2.2% during the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock valued at $476,000 after buying an additional 75 shares during the period. Massmutual Trust Co. FSB ADV grew its holdings in shares of Clorox by 17.2% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock valued at $83,000 after acquiring an additional 75 shares in the last quarter. Finally, Empower Advisory Group LLC increased its stake in shares of Clorox by 4.5% in the third quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock worth $297,000 after acquiring an additional 78 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of analysts recently issued reports on CLX shares. DA Davidson lifted their price objective on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $167.00 to $171.00 and gave the company a “neutral” rating in a research note on Thursday, January 16th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, Wells Fargo & Company raised shares of Clorox from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $155.00 to $157.00 in a research report on Tuesday, January 7th. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $156.54.
Clorox Stock Down 0.7 %
CLX opened at $158.91 on Thursday. The business has a 50 day moving average of $164.06 and a 200-day moving average of $157.10. The stock has a market capitalization of $19.67 billion, a price-to-earnings ratio of 55.37, a P/E/G ratio of 2.95 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business’s revenue was up 27.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.49 EPS. As a group, sell-side analysts anticipate that The Clorox Company will post 6.87 earnings per share for the current year.
Clorox Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a yield of 3.07%. Clorox’s dividend payout ratio is 170.04%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Oracle Announces Game-Changing News for the AI Industry
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- What to Know About Investing in Penny Stocks
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.